BTA-9881

• Description :

  BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  390.82

• Molecular Formula :

  C21H15ClN4O2

• Notes :

  Research use only, not for human use.

• Receptor :

  RSV

• CAS Number :

  1646857-24-0